A Phase 1/2 clinical trial evaluating the investigational gene therapy 4D-310, developed by 4D Molecular Therapeutics (4DMT) for people with Fabry ...
https://www.google.com/url?rct=j&sa=t&url=https://fabrydiseasenews.com/2021/04/16/phase-1-2-trial-of-4dmt-gene-therapy-4d-310-for-fabry-disease-doses-first-patient/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGTeF0KhGOSaeQVwb2Ce6TpHUt3LA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.